VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
40 hedge funds and large institutions have $122M invested in Verona Pharma in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.28% less ownership
Funds ownership: 7.55% → 7.27% (-0.28%)
33% less capital invested
Capital invested by funds: $182M → $122M (-$59.7M)
Holders
40
Holding in Top 10
4
Calls
$388K
Puts
–
Top Buyers
| 1 | +$2.1M | |
| 2 | +$207K | |
| 3 | +$200K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$160K |
| 5 |
Renaissance Technologies
New York
|
+$118K |
Top Sellers
| 1 | -$3.74M | |
| 2 | -$3.33M | |
| 3 | -$1.84M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.5M |
| 5 |
PA
Perceptive Advisors
New York
|
-$541K |